FDA panel backs J&Js newclass antidepressant
FDA panel backs J&J’s new-class antidepressant
06:19 EST 13 Feb 2019 |
PMLIVE
Set to be first novel antidepressant approved since Prozac in 1987
Original Article: FDA panel backs J&J’s new-class antidepressant
More From BioPortfolio on "FDA panel backs J&J’s new-class antidepressant"